Like I've been saying --- who says LL "needs" typi
Post# of 145358
This drug is potentially so powerful, it could very well draw a consortium of investors, who secure a syndicate of bank funding, post very post LL results, on a couple of vastly different diseases.
Alot of old, entrenched business models, have been worked around, & become extinct.
The Samsung move is still very interesting, when combined with some of the patents.
My bet is Ai is also for a Continuous Manufacturing facility.
Shall see....
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)